secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2022-01-28T23:59:59+00:00
Accession:  0001193125-22-020673
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology COO & EVP of Finance Douglas Carlson resigns; interim PAA named
------------------------------------------------------------------------------

- Douglas R. Carlson resigns as COO and EVP of Finance, effective Feb 18, 2022, to pursue other opportunities.
- Francisco Oliveira, Head of Finance and Administration since 2019, named interim Principal Accounting Officer.
- Oliveira will report to CEO Mark Manfredi while a formal search for a new CFO is conducted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312522020673/0001193125-22-020673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312522020673/d258896d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-020673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer